Section 3. Colombian consensus on the diagnosis and treatment of extrapulmonary aspergillosis in adult patients
dc.contributor.author | Oñate, José M. | |
dc.contributor.author | Rivas Pinedo, Pilar | |
dc.contributor.author | Castañeda Luquerna, Ximena | |
dc.contributor.author | Marín Uribe, Jorge I. | |
dc.contributor.author | Berrio, Indira | |
dc.contributor.author | Fernández Suarez, Hugo | |
dc.contributor.author | Osorio Lombana, Juan P. | |
dc.contributor.author | Cuervo Maldonado, Sonia I. | |
dc.contributor.author | Saavedra Trujillo, Carlos H. | |
dc.contributor.author | Celis, Adriana Marcela | |
dc.contributor.author | Álvarez Moreno, Carlos A. | |
dc.contributor.author | Gómez Rincón, Julio C. | |
dc.contributor.author | Restrepo Gualteros, Sonia | |
dc.contributor.author | Camacho Moreno, Germán | |
dc.contributor.author | Enciso Olivera, Leonardo | |
dc.contributor.author | Patiño Escobar, Bonell | |
dc.contributor.author | Guevara, Fredy | |
dc.contributor.author | Patiño Niño, Jaime | |
dc.contributor.author | Montufar, Franco | |
dc.contributor.author | López Medina, Eduardo | |
dc.contributor.author | Fernández Chico, Dinno | |
dc.contributor.author | García Goez, José F. | |
dc.contributor.author | Pallares G., Christian | |
dc.date.accessioned | 2023-05-02T16:16:37Z | |
dc.date.available | 2023-05-02T16:16:37Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Las manifestaciones clínicas de las enfermedades asociadas a Aspergillus spp. son variables y dependen de la interacción entre la dosis inoculante (que se desconoce y probablemente varía mucho), la capacidad del paciente para resistir la infección tanto a nivel local como sistémico y la virulencia del agente etiológico. La mayor dificultad para establecer un esquema de clasificación clínica radica en la existencia de un espectro amplio y continuo de la enfermedad, asociado a un diagnóstico y un manejo clínico complicados. Una AI puede presentarse como una infección localizada en un órgano, o como parte de una infección diseminada, que se presenta en un variado espectro de cuadros clínicos. Sin embargo, no se han completado ensayos clínicos para evaluar los diferentes enfoques terapéuticos específicos según el tipo de afectación en estos pacientes. Las formas clínicas más frecuentes de aspergilosis invasiva (AI) se presentan en el pulmón y los senos paranasales, la aspergilosis pulmonar crónica (APC) puede complicarse con la diseminación a estructuras contiguas como el espacio pleural, el pericardio, la pared torácica y estructuras mediastínicas como el esófago y los grandes vasos. Con frecuencia se extiende más allá de las vías respiratorias y puede afectar a la piel, el SNC, los ojos, el hígado, los riñones y otras estructuras. | spa |
dc.description.abstractenglish | The clinical manifestations of Aspergillus spp. associated diseases are variable and depend on the interaction between the inoculating dose (which is not known and probably varies widely), the patient’s ability to resist infection at both local and systemic level, and the virulence of the etiologic agent. The major difficulty in establishing a clinical classification scheme lies in the existence of a broad and continuous spectrum of disease, associated with a complicated diagnosis and clinical management. An IA can present as a localized infection in one organ, or as part of a disseminated infection, which presents itself in a varied spectrum of clinical pictures. However, no clinical trials have been completed to evaluate the different specific therapeutic approaches according to the type of involvement in these patients. The most common clinical forms of invasive aspergillosis (IA) occur in the lung and paranasal sinuses, chronic pulmonary aspergillosis (CPA) can be complicated by spreading to contiguous structures such as the pleural space, pericardium, chest wall and mediastinal structures such as the esophagus and great vessels. It frequently spreads beyond the respiratory tract, and can affect the skin, CNS, eyes, liver, kidneys and other structures. | eng |
dc.format.mimetype | application/pdf | |
dc.identifier.doi | https://doi.org/10.22354/24223794.1065 | |
dc.identifier.instname | instname:Universidad El Bosque | spa |
dc.identifier.issn | 0123-9392 | |
dc.identifier.reponame | reponame:Repositorio Institucional Universidad El Bosque | spa |
dc.identifier.repourl | repourl:https://repositorio.unbosque.edu.co | |
dc.identifier.uri | https://hdl.handle.net/20.500.12495/10345 | |
dc.language.iso | eng | |
dc.publisher | Asociacion Colombiana de Infectologia | spa |
dc.publisher.journal | Infectio | spa |
dc.relation.ispartofseries | Infectio, 0123-9392, 26, 3, 2022, 297-339 | spa |
dc.relation.uri | https://revistainfectio.org/P_OJS/index.php/infectio/article/view/1065 | |
dc.rights.accessrights | https://purl.org/coar/access_right/c_14cb | |
dc.rights.accessrights | info:eu-repo/semantics/closedAccess | |
dc.rights.accessrights | Acceso cerrado | |
dc.subject | Aspergilosis | spa |
dc.subject | Aspergillus | spa |
dc.subject | Guias de práctica clínica | spa |
dc.subject | Aspergilosis invasiva | spa |
dc.subject | Diagnostico de Aspergillus | spa |
dc.subject | Voriconazol | spa |
dc.subject | Posaconazol | spa |
dc.subject | Isavuconazol | spa |
dc.subject | Cas-pofungina | spa |
dc.subject | Micafungina | spa |
dc.subject | Anidulafungina | spa |
dc.subject | Anfotericina B | spa |
dc.subject | Aspergilosis extra pulmonar | spa |
dc.subject | Sistema nervioso central | spa |
dc.subject | Endocarditis | spa |
dc.subject | Sinusitis | spa |
dc.subject | Osteomielitis | spa |
dc.subject | Endoftalmitis | spa |
dc.subject.keywords | Aspergillosis | spa |
dc.subject.keywords | Aspergillus | spa |
dc.subject.keywords | Guidelines | spa |
dc.subject.keywords | Invasive aspergillosis | spa |
dc.subject.keywords | Aspergillus diagnosis | spa |
dc.subject.keywords | Voriconazole | spa |
dc.subject.keywords | Posaconazole | spa |
dc.subject.keywords | Isavuconazole | spa |
dc.subject.keywords | Caspofungin | spa |
dc.subject.keywords | Micafungin | spa |
dc.subject.keywords | Anidulafungin | spa |
dc.subject.keywords | Amphotericin B | spa |
dc.subject.keywords | Extra pulmonary aspergillosis | spa |
dc.subject.keywords | Central nervous system;endocarditis | spa |
dc.subject.keywords | Central nervous system | spa |
dc.subject.keywords | Endocarditis | spa |
dc.subject.keywords | Sinusitis | spa |
dc.subject.keywords | Osteomyelitis | spa |
dc.subject.keywords | Endophthalmitis | spa |
dc.title | Section 3. Colombian consensus on the diagnosis and treatment of extrapulmonary aspergillosis in adult patients | spa |
dc.title.translated | Sección 3. Consenso colombiano para el diagnóstico y tratamiento la aspergilosis extrapulmonar en pacientes adultos | spa |
dc.type.coar | https://purl.org/coar/resource_type/c_6501 | |
dc.type.coarversion | https://purl.org/coar/version/c_970fb48d4fbd8a85 | |
dc.type.driver | info:eu-repo/semantics/article | |
dc.type.hasversion | info:eu-repo/semantics/publishedVersion | |
dc.type.local | Artículo de revista |
Archivos
Bloque original
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- Section 3. Colombian consensus on the diagnosis and treatment of extrapulmonary aspergillosis in adult patients.pdf
- Tamaño:
- 720.85 KB
- Formato:
- Adobe Portable Document Format
- Descripción:
- Section 3. Colombian consensus on the diagnosis and treatment of extrapulmonary aspergillosis in adult patients
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 1.95 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: